PROTALIX BIOTHERAPEUTICS INC - COM (PLX)

CUSIP: 74365A101

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
8,278,407
Share change
+1,274,760
Total reported value
$4,463,738
Put/Call ratio
386%
Price per share
$0.54
Number of holders
35
Value change
+$573,815
Number of buys
15
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 74365A101?
CUSIP 74365A101 identifies PLX - PROTALIX BIOTHERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PROTALIX BIOTHERAPEUTICS INC - COM (PLX) as of Q1 2018

As of 31 Mar 2018, PROTALIX BIOTHERAPEUTICS INC - COM (PLX) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,278,407 shares. The largest 10 holders included Opaleye Management Inc., RENAISSANCE TECHNOLOGIES LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, BRIDGEWAY CAPITAL MANAGEMENT INC, SG Americas Securities, LLC, MEITAV DASH INVESTMENTS LTD, UBS Group AG, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and WELLS FARGO & COMPANY/MN. This page lists 35 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.